- Home
- QRTEA vs GALT Comparison
QRTEA vs GALT Comparison
Compare QRTEA & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRTEA
- GALT
- Stock Information
- Founded
- QRTEA 1991
- GALT 2000
- Country
- QRTEA United States
- GALT United States
- Employees
- QRTEA N/A
- GALT N/A
- Industry
- QRTEA Catalog/Specialty Distribution
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- QRTEA Consumer Discretionary
- GALT Health Care
- Exchange
- QRTEA Nasdaq
- GALT Nasdaq
- Market Cap
- QRTEA 165.8M
- GALT 147.8M
- IPO Year
- QRTEA N/A
- GALT N/A
- Fundamental
- Price
- QRTEA $0.35
- GALT $1.04
- Analyst Decision
- QRTEA
- GALT Strong Buy
- Analyst Count
- QRTEA 0
- GALT 1
- Target Price
- QRTEA N/A
- GALT $11.00
- AVG Volume (30 Days)
- QRTEA 2.5M
- GALT 1.1M
- Earning Date
- QRTEA 11-07-2024
- GALT 11-13-2024
- Dividend Yield
- QRTEA N/A
- GALT N/A
- EPS Growth
- QRTEA N/A
- GALT N/A
- EPS
- QRTEA N/A
- GALT N/A
- Revenue
- QRTEA $10,236,000,000.00
- GALT N/A
- Revenue This Year
- QRTEA N/A
- GALT N/A
- Revenue Next Year
- QRTEA N/A
- GALT N/A
- P/E Ratio
- QRTEA N/A
- GALT N/A
- Revenue Growth
- QRTEA N/A
- GALT N/A
- 52 Week Low
- QRTEA $0.32
- GALT $0.73
- 52 Week High
- QRTEA $1.80
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- QRTEA 32.95
- GALT 20.80
- Support Level
- QRTEA $0.36
- GALT $1.80
- Resistance Level
- QRTEA $0.46
- GALT $2.36
- Average True Range (ATR)
- QRTEA 0.03
- GALT 0.27
- MACD
- QRTEA -0.00
- GALT -0.08
- Stochastic Oscillator
- QRTEA 3.54
- GALT 15.07
About QRTEA Qurate Retail Inc. Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.